IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Recurrent Marginal Zone Lymphoma
Fred Hutchinson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 89/ 100
Competitive context
22 Active assets in the Recurrent Marginal Zone Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE University of Miami | Phase 2 | BBB |
Fludarabine Paolo Caimi, MD | Phase 2 | BBB |
FILGRASTIM Fred Hutchinson Cancer Center | Phase 2 | BBB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 2 | BBB |
Cediranib City of Hope Medical Center | Phase 2 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →